Category: Poland

  • DWF Advises Elawan Energy on Sale of 18-Megawatt PV Portfolio to R.Power

    DWF has advised Elawan Energy on the sale of an 18-megawatt portfolio of photovoltaic projects in Poland to R.Power.

    Madrid-headquartered Elawan Energy, part of the Japanese ORIX Group, is an operator in the renewable energy industry.

    R.Power is a solar energy company.

    According to DWF, “the transaction concerned the sale of a portfolio of photovoltaic projects located in the West Pomeranian and Greater Poland voivodeships with a cumulative capacity of 18 megawatts. This sale falls within Elawan’s non-core asset divestment program. The projects have been developed to a ready-to-build status and are intended for construction in 2024.”

    The DWF team included Partners Karol Lasocki and Rafal Wozniak, Local Partner Malgorzata Lesiak-Cwikowska, Associates Mateusz Bak and Katarzyna Stefaniak, and Junior Associates Joanna Szczech and Patrycja Strycharek.

  • Dentons and DLA Piper Advise on Globalworth EUR 145 Million Financing from Aareal Bank

    Dentons has advised Globalworth on the EUR 145 million financing from Germany’s Aareal Bank AG to refinance its obligations regarding the Skylight and Lumen office complex and the Hala Koszyki multifunctional facility in Warsaw. DLA Piper advised Aareal Bank.

    Part of the Globalworth portfolio since 2018, the Skylight and Lumen buildings are, according to Dentons, “among the best-known office buildings in Warsaw, located in the immediate vicinity of the Zlote Tarasy shopping gallery.” Hala Koszyki, designed in the Art Nouveau style and erected over 100 years ago as a market hall, has been partially restored and reopened in 2016 as a modern multifunctional facility. All properties covered by the financing are BREEAM certified with a rating of Excellent, the firm reported.

    Globalworth is a real estate company and office investor in Central and Eastern Europe, with a focus on Poland and Romania. The firm is listed on the AIM segment of the London Stock Exchange.

    The Dentons team was led by Partner Piotr Nerwinski and included Counsel Patrycja Polasz and Associate Aleksandra Grzeskowiak.

    The DLA Piper team was led by Partner Mariusz Hyla and included Senior Associate Anna Jarczok, Associate Ewelina Szlachcic, and Junior Associate Daniel Jakubiak.

  • Allen & Overy and CMS Advise on EUR 125 Million Financing for G City Europe’ Promenada in Warsaw

    Allen & Overy has advised Bank Pekao and Berlin Hyp on a EUR 125 million financing to G City Europe for the Promenada shopping center in Warsaw. CMS advised G City Europe.

    According to Allen & Overy, “the Promenada is a prominent shopping center in Warsaw benefiting from a prime location, a loyal customer base, and a strong sponsor – G City Europe (formerly Atrium European Real Estate) with a proven track record in the Polish retail sector.”

    The Allen & Overy team included Partners Anna Madra and Michal Matera, Consultant Bartosz Jagodzinski, Counsel Piotr Przybylski, Senior Associate Artur Rutkowski, and Associates Katarzyna Fus-Starzec, Michal Galuszynski, Maria Korba, and Michal Jakub Rudzki.

    The CMS team included Partner Jakub Wieczorek, Senior Associate Karolina Zajac, and Lawyers Martyna Adamowicz and Karol Scibor.

  • Norton Rose Fulbright Advises BGK on CRR-Compliant Counter-Guarantee for Alior Bank

    Norton Rose Fulbright has advised Bank Gospodarstwa Krajowego on amendments to the documentation regarding a CRR-compliant counter-guarantee between Bank Gospodarstwa Krajowego and Powszechny Zaklad Ubezpieczen in favor of Alior Bank.

    According to Norton Rose, “the maximum commitment with respect to any guarantees that may be given under the guarantee agreement signed between Powszechny Zaklad Ubezpieczen and Alior Bank is PLN 4 billion (approximately USD 985 million). This limit applies for three years and is revolving, i.e., when a guarantee expires, the limit is topped up with the “released” amount minus any potential payments under the guarantee.”

    Additionally, pursuant to the related counter-guarantee agreement, “BGK is to give, at the request of PZU, counter-guarantees issued for the benefit of Alior Bank, with the available counter-guarantee limit as PLN 3.2 billion (approximately USD 788 million).”

    The Norton Rose team included Partner Tomasz Rogalski, Senior Associate Daniel Popek, and Associate Karolina Majcher.

  • Public to Private Transactions Are Currently Becoming More and More Difficult

    Due to Polish regulations on takeover offers for publicly traded companies, public to private transactions now carry a heavier risk of failure, understood as the inability to delist the company from the exchange. The bid for shares of TIM S.A., recently extended until 6 December 2023, may be a case in point. Any investor who gets involved in a tender for shares of a listed company needs to ponder the risk that, once the transaction is finalised, they will acquire a controlling stock in a listed company, which may still be subject to a restricted trading regime applicable to public companies for quite some time.

    At present, some pending takeover bids may end up with the delisting of major companies listed on the Warsaw Stock Exchange. Along with the bid for shares of TIM S.A., we are now witnessing the final stage of delisting the shares of STS Holding (the shares have been unlisted since 5 October) or Alumetal, which the Polish FSA agreed to delist on 28 November 2023. A forced buyout for the stock of Ciech was launched on 17 November 2023 by its leading shareholder, KI Chemistry, bringing an end to the series of bids for these shares. Despite a legal dispute between its shareholders, Kernel Holding is now close to delisting as well. A bid aimed at delisting the company was also announced by the key shareholders of Newag. The press estimates the total value of entities which may soon disappear from the Warsaw Stock Exchange at PLN 16 billion.

    As next bids are announced under the regulations that were introduced last year, the market becomes increasingly better at identifying any corresponding constraints. In general, two rules notably shape the takeovers of public companies made with the goal to subsequently withdraw from public trading and remain determinant for the transaction: the first sets forth how possible conditions precedent for the acquisition of shares can be defined under the bid, and the other defines the maximum deadline for accepting bidding subscriptions.

    In order for the process to run smoothly and to achieve its intended goal, the investor should purchase shares representing at least 95% of voting rights in the company, as this is the threshold that will allow them to squeeze out the minority shareholders. The tendency is now quite perceptible in the Polish market. Since the entry into force of the new regulations, some bids have been made where the bidder failed to eventually secure 95% of the votes at the general meeting of shareholders and the company kept its listing status, temporarily. As a matter of fact, even a substantial price premium is often not enough for the bidder to always successfully achieve their intended transaction goal, and legal requirements may become a hurdle. This was the case in the first bid for the shares of TIM S.A.; shortly before the end of the acceptance period (already extended once), the Office of Competition and Consumer Protection (UOKiK) made the decision to prolong its antitrust proceedings by 4 months.

    In the aforementioned case, no extension for the voluntary bid is possible under the existing legal framework, and the offer acceptance deadline may not be extended as required to get the relevant consent from the regulator by more than 120 days in total. As a result, because the UOKiK proceedings were prolonged, one of the bidding conditions could not be met, which then prevented the intended transaction from successful closing. The offer ended without any shares being acquired.

    Less than a month after the condition under the first bid was not met, FEGA & Schmitt Elektrogroßhandel GmbH announced a new, same-price tender for the shares of TIM S.A., and the bid was recently extended until 6 December 2023. The bid was made under the condition that the antitrust authorities approve the transaction. The investor now stresses that they are in an on-going conversation with the UOKiK and that they are fully cooperating with the Office.

    Any circumstances which are beyond the control of the investor or the company itself, for instance the obligation to get the antimonopoly consent or lengthy administrative proceedings, should not be an obstacle to running a bid, and the bidder should have the option to extend its deadline until the regulatory proceedings are over. If one needs to make a new bid in order to address legislative constraints, one also needs to redetermine the bid price, in line with the requirements set forth in the legislative act. This situation proves unequivocally that the rules on takeover bids are not flexible enough.

    One more issue may make voluntary bids intended for delisting less effective, namely the requirement to define the minimum number of shares under the bid which, once reached, will impose on the investor the obligation to acquire the shares covered by the bid. The minimum threshold for shares acquired under the bid, which includes shares already held by the investor, cannot not be set at more than 50% of the total number of votes at the general meeting. It’s worth noting that the threshold which allows the investor to perform the squeeze-out of minority shareholders is at 95% of votes.

    The spread between the respective thresholds – 50% and 95% of votes – is very big, and the risk that after the acquisition of shares the investor will be a holder of a listed company is similar. In other words, the investor needs to ponder that risk when they enter the transaction.

    Said regulations negatively affect the possibility of acquiring majority shareholdings in public companies and require investors to devise a multi-stage acquisition plan when they eventually aim for delisting. The same applies to larger companies which may be subject to quite complex antitrust proceedings or are covered by a specific regulatory regime. Here, the investor also needs to recognise that the transaction may not be finalised under a single bid, and that a new bid will need to be made under the new conditions. For this reason, it is vital to prepare an adequate transaction structure to help the investor get closer to their intended goal, in other words, the delisting of the company.

    Over the last five years, more than 80 companies have been delisted from the Warsaw Stock Exchange. Furthermore, the number of successful bids for shares has decreased in recent years; in 2020, there were 30, in 2021 the number was reduced to 28, subsequently dropping in 2022 to only 21.

    By Marcin Pietkiewicz, Partner, and Katarzyna Jaroszynska-Lewand, Senior Associate, Wolf Theiss

  • Wolf Theiss Advises Deutsche Hypo-NORD/LB on EUR 46 Million Financing for Acquisition of Mokotow Nova

    Wolf Theiss has advised Deutsche Hypo-NORD/LB Real Estate Finance on the financing for Rysy Properties Limited’s EUR 46 million acquisition of the Mokotow Nova office building in Warsaw from CCP III Netherlands Holding.

    According to Wolf Theiss, “situated in Warsaw’s Mokotow district at 22 Woloska Street, the Mokotow Nova office building, managed by Colliers International, began construction in 2010 and was completed in January 2012. With an eleven-story structure, the property features a total usable area of 43,000 square meters, 40,000 of which are devoted to office space and another 3,000 to retail and service space.”

    The Wolf Theiss team included Partners Przemek Kozdoj and Anna Tomowicz and Associates Jan Gasiorowski and Maria Markowska.

    Editor’s Note: After this article was published, CEE Legal Matters learned that Dentons advised Tristan Capital Partners as the seller of Mokotow Nova, while Greenberg Traurig advised the buyer.

    The Dentons team included Partner Magdalena Szwarc-Brozyna, Counsel Justyna Jamrozy, Senior Associate Paulina Dabek, and Associates Karolina Kordulska and Maciej Kulpinski.

    The Greenberg Traurig team included Partner Agnieszka Stankiewicz, Counsel Karolina Kuzniak, and Junior Associate Ernest Kraczkowski.

  • Gessel Advises Orthos Multidisciplinary Hospital on Land Acquisition

    Gessel has advised the Orthos Multidisciplinary Hospital – part of the Lux Med network – on the acquisition of a 1.1-hectare agricultural property bordering its premises.

    The Orthos Multidisciplinary Hospital is located in Komorowice, near Wroclaw, in Poland, and provides a range of diagnostic, therapeutic, and rehabilitation services.

    Gessel also advised on Lux Med Group’s investment in the Orthos hospital and clinic a few months earlier (as reported by CEE Legal Matters on July 17, 2023).

    The Gessel team included Partner Maciej Boryczko, Senior Consultant Iwona Gielo-Benza, and Associate Walentyna Okun.

    The firm did not respond to our inquiry on the matter.

  • Reed Smith and C&G Advise on Wind Point Partners Acquisition
of Assisi Pet Care

    Reed Smith has advised Wind Point Partners on its acquisition of Assisi Pet Care. Czabanski & Galuszynski, working with Addleshaw Goddard, advised the Crescent Capital Group on providing financing for the acquisition.

    The Assisi Pet Care Group is a manufacturer of dog and cat treats. Headquartered in the UK, Assisi distributes its products locally and throughout Europe, with two of its production facilities located in Poland. It works with customers across the grocery, e-commerce, and pet specialty channels.

    Wind Point Partners is a Chicago-based private equity firm.

    The  Los Angeles-based Crescent Capital Group is an alternative investment firm specializing in below-investment-grade credit markets and focusing on leveraged loans, high-yield bonds, mezzanine debt, special situations, and distressed securities.

    “We appreciate being able to continue our financing partnership as Assisi Pet Care enters its next phase of growth with Wind Point Partners,” Crescent Managing Director and Head of European Specialty Lending Strategy Christine Vanden Beukel commented. “We believe the company is strongly positioned in the attractive, fast-growing natural treats and natural pet food segment.”

    The Reed Smith team advising Wind Point included Partners Sam Webster, Bradley Schmarak, Ravi Pattani, Linn Mayhew, and Kevin-Paul Deveau, Counsel Dimos Papanikolaou, and Associates Victoria Bryden, James Hatchard, Saiya Guo, Roxana Burghel, Eleni Alexiou, Billy Fraser, Goksu Gokay, Louisa Martac, and Tamari Gvinianidze.

    The C&G team was led by Partner Piotr Galuszynski and included Attorney at Law Urszula Rachwol, Managing Associate Adam Janczewski, Associate Katarzyna Pasek, and Intern Iga Karasinska.

  • Schoenherr Advises Dr. Schneider’s Group Insolvency Administrator on EUR 118.3 Million Sale to Samvardhana Motherson

    Schoenherr has advised Joachim Exner – the insolvency administrator of Dr. Schneider’s Group – on the sale of its business to the Samvardhana Motherson Group for EUR 118.3 million. Friedrich Graf von Westphalen advised Motherson. DZP and Ashurst reportedly advised the sellers.

    The acquisition aligns with Motherson Group’s vision to strengthen its foothold in the automotive components sector, Schoenherr announced. “This acquisition on the Polish market is strategically positioned to enhance the group’s capabilities and market share within the automotive supply chain.”

    The Samvardhana Motherson Group is a wholly-owned subsidiary of India’s Samvardhana Motherson International Limited. The Motherson Group is represented in 41 countries.

    Dr. Schneider’s Group is a German supplier of electronic components and polymer systems for brands such as Jaguar, Audi, Maserati, and Daimler. It has 4,500 employees across seven production plants in Germany, Spain, Poland, the US, and China.

    The Schoenherr team was led by Partner Pawel Halwa and included Counsels Krzysztof Wawrzyniak and Daniel Radwanski and Attorney at Law Hanna Kosinska.

  • MFW Fialek and EY Law Advise on Scanmed Group’s Acquisition of Med-Lux

    MFW Fialek has advised the Scanmed medical group on the acquisition of Med-Lux. EY Law advised Med-Lux.

    The Scanmed medical group is a private medical operator. It is a portfolio company of the Abris Capital Partners fund, an independent private equity fund manager investing in Central Europe.

    Med-Lux is a provider of primary healthcare, specialized outpatient care, occupational medicine, and physiotherapy in medical centers near the city of Poznan.

    The MFW Fialek team included Partner Miroslaw Fialek, Counsel Michal Karwacki, Senior Associate Pawel Siwiec, Associates Michal Kret, Maksymilian Kulczycki, Wojciech Lichterowicz, Mateusz Wieckowski, and Cezary Gizinski, and Junior Associate Natalia Grzegorzewska.

    The EY Law team included Partner Magdalena Kasiarz, Counsel Andrzej Laprus, and Associate Marta Sadowska.